| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Metabolism of spingolipids in er and golgi apparatus 0.8250825082508068 2.4239676462199213 0.015351973132172 0.9999203071929608 0.7793671823131502 7 Q16880,Q9NRA0,Q10472,O95470,Q06136,Q16739 6 |
| Oxidation by cytochrome p450 0.8993556713212477 2.3847926588697987 0.01708874967392 0.9999728526989968 0.7793671823131502 5 P16435,O43169,Q6UW02 3 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.9005182001268168 2.26923526613309 0.023254022736302 0.9999994154858008 0.7793671823131502 4 Q01650 1 |
| Mitochondrial complex iv assembly 0.8116684805810054 2.244608713465324 0.0247932628942983 0.9999997766516924 0.7793671823131502 16 Q7KZN9,P00403,P14406,Q9Y241,Q9Y2R0,Q8N8Q8,P0DJ07,P13073,Q96I36 9 |
| Sphingolipid metabolism overview 0.7952993353304711 2.243494299238256 0.0248649570664698 0.9999997864468996 0.7793671823131502 10 Q16880,Q9NRA0,O95470,Q96G23,P27544,Q06136,Q16739 7 |
| Sphingolipid metabolism integrated pathway 0.7952993353304711 2.243494299238256 0.0248649570664698 0.9999997864468996 0.7793671823131502 10 Q16880,Q9NRA0,O95470,Q96G23,P27544,Q06136,Q16739 7 |
| Kennedy pathway from sphingolipids 0.7821685151369048 2.2285749637337076 0.025842198405392 0.9999998841540388 0.7793671823131502 7 Q9Y6K0,P35790,Q9HBU6,Q9UG56,O95470 5 |
| Cholesterol biosynthesis with skeletal dysplasias 0.8222734662689328 2.1772445146369788 0.0294623286043886 0.9999999880446504 0.7793671823131502 6 Q15392,Q14739,Q9UBM7,Q16850 4 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.7679439747639416 2.162790799931197 0.030557273534604 0.9999999939949656 0.7793671823131502 7 P09601 1 |
| Proteoglycan biosynthesis 0.7581585080758216 2.117241151972164 0.0342393864746086 0.9999999994106292 0.7793671823131502 7 Q8NCH0,Q8WVQ1,Q9NX62,Q8TB61 4 |
| Intracellular trafficking proteins involved in cmt neuropathy 0.7578605564116616 2.099484289307445 0.0357742313192921 0.9999999997766286 0.7793671823131502 8 Q9NR77,P07196 2 |
| Zinc homeostasis 0.8321132157558129 1.981654051078216 0.047517973209709 0.9999999999998732 0.787468937018389 4 Q8N1S5 1 |
| Copper homeostasis 0.7282341895211367 1.9595358377719017 0.0500500671380113 0.999999999999975 0.787468937018389 8 P78536,O75880,P05067,O43819 4 |
| Triacylglyceride synthesis 0.7959417263223552 1.941617804378302 0.0521833858690226 0.9999999999999936 0.787468937018389 5 Q9HCL2 1 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.7081547387608618 1.8807620322819123 0.0600042970951302 1.0 0.814622569854086 7 Q07820 1 |
| Sphingolipid metabolism in senescence 0.721222209077446 1.8780090807126155 0.0603799228537733 1.0 0.814622569854086 11 P11802,P04062,Q96G23,Q06136,Q16739 5 |
| Ccl18 signaling pathway 0.702525214612366 1.7871974293011383 0.0739055846689205 1.0 0.814622569854086 11 Q96GC9,Q86UE4,P00403,P08670 4 |
| Mitochondrial complex iii assembly 0.6975676177277533 1.7629814089801938 0.0779036252601055 1.0 0.814622569854086 11 Q9UDW1,O14949 2 |
| Photodynamic therapyinduced ap1 survival signaling 0.6835941461046975 1.762384853337706 0.0780042960097204 1.0 0.814622569854086 7 Q07820 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.7471137987905256 1.7254175232407452 0.0844522555936728 1.0 0.814622569854086 5 Q03252,O60725,P02545,P49354 4 |
| Sphingolipid pathway 0.689022462018122 1.7211099512084074 0.0852308738689937 1.0 0.814622569854086 11 Q16880,Q9NRA0,P04062,O95470,Q96G23,Q06136,Q16739 7 |
| Glycerolipids and glycerophospholipids 0.66798452825715 1.6683949403150853 0.0952373520248182 1.0 0.8664421397203934 8 Q9UG56,Q9HCL2 2 |
| Glycerophospholipid biosynthetic pathway 0.6703248676029823 1.6454009078951657 0.0998871624600779 1.0 0.8664421397203934 10 Q9Y6K0,Q8WUK0,O95674,Q9HCL2 4 |
| Nanomaterial induced apoptosis 0.7269784419986087 1.6351139169969096 0.1020251692506335 1.0 0.8664421397203934 5 Q9NR28,O95831 2 |
| Amyotrophic lateral sclerosis als 0.6603127223823596 1.595915670682719 0.1105076223262244 1.0 0.8740872889139545 10 Q9BUN8,P07197,P07196,O96008 4 |
| Bladder cancer 0.7170339979599928 1.5902940526884908 0.11176853858244 1.0 0.8740872889139545 5 P11802 1 |
| Familial partial lipodystrophy fpld 0.6488979536474586 1.5744587398635943 0.1153814331329234 1.0 0.8875727495775202 8 O75844,P49354,P31751,O60725,P02545,Q03252 6 |
| Vitamin d metabolism 0.8728021978021981 1.570052131872033 0.1164029835511502 1.0 0.8875727495775202 3 Q9UBM7,P38435 2 |
| Cellular proteostasis 0.7015996076826747 1.520468500632149 0.1283932696340599 1.0 0.8992936006179414 5 O15212,Q9UHV9,Q99471 3 |
| Electron transport chain oxphos system in mitochondria 0.6694388414481002 1.504017755289358 0.1325767951034722 1.0 0.8992936006179414 60 O75380,P00403,P14406,O75964,O43676,P00846,O14949,P13073,P06576,Q7KZN9,Q9UDW1,O43674,O75438,P20674,O95168,O95167,P21912,P09669,O14548,P03886,O96000,P12236,Q9Y6M9,P24539,P36542,O95169,O95139,O75880,P56385,P12235 30 |
| Mitochondrial immune response to sarscov2 0.6212876931866735 1.4373009707523916 0.1506324931526892 1.0 0.8992936006179414 8 Q9Y6M9 1 |
| Striated muscle contraction pathway 0.6576715049244993 1.4287268652816985 0.1530827530492209 1.0 0.8992936006179414 6 O43707,P08670,P09493 3 |
| Nocgmppkg mediated neuroprotection 0.6682563447597197 1.368714161462143 0.1710886418569819 1.0 0.9426226944111028 5 P07196,P30536 2 |
| Statin inhibition of cholesterol production 0.5981332936954564 1.340430354989366 0.180105472509485 1.0 0.9722507808034148 7 P37268,P02654,Q14534,Q8WTV0 4 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.6218167472033783 1.3221815967533688 0.1861076876996839 1.0 0.9871799086678884 15 O75844,P50402,O60725,P11802,P42167 5 |
| Mitochondrial complex i assembly model oxphos system 0.6442538659343243 1.240124990782204 0.2149291668209278 1.0 0.994805206924383 36 Q9P0J0,O75438,Q96CU9,O75380,Q9BUB7,Q9NW81,O95168,O95167,P03886,O43676,O95169,O95139,O96000,Q9Y6M9,Q8IUX1,Q9NPL8,O43674 17 |
| Praderwilli and angelman syndrome 0.5802242380985752 1.2310807745975747 0.2182926552503543 1.0 0.994805206924383 8 Q96RK4,P04637,P11802,Q7L576 4 |
| Cholesterol biosynthesis pathway 0.5973886914037634 1.2128658175143991 0.2251811264375058 1.0 0.994805206924383 14 Q9UBM7,P14324,Q16850,Q15800,Q14534,O75845,P37268 7 |
| Reninangiotensinaldosterone system raas 0.7802197802197809 1.2094334063352692 0.2264963809166915 1.0 0.994805206924383 3 Q13555,Q14012 2 |
| Relationship between inflammation cox2 and egfr 0.6298799382703288 1.193114484230341 0.2328245396694959 1.0 0.994805206924383 5 P31751 1 |
| Vitamin b12 disorders 0.651864331319427 1.1923786738280782 0.2331127985410361 1.0 0.994805206924383 4 Q9NPF0,P22033 2 |
| Nonalcoholic fatty liver disease 0.6224405205406783 1.1875856867990968 0.2349966796430025 1.0 0.994805206924383 59 Q96GC9,O75380,P00403,P14406,O43676,P56556,O14949,P13073,Q9UDW1,O43674,Q9P0J0,O75438,P20674,O95168,O95167,Q86Y39,P21912,P09669,O14548,P31751,O96000,Q9Y6M9,O95169,O95139 24 |
| Oxidative phosphorylation 0.6360309557937344 1.1875813392076668 0.2349983933405501 1.0 0.994805206924383 38 O75438,O75380,O95168,O95167,O75964,Q86Y39,P03886,P00846,P24539,O95169,O96000,O95139,P06576,Q9Y6M9,P56385,O43674,O75787 17 |
| Influence of laminopathies on wnt signaling 0.575865354633692 1.1536976685871674 0.2486241400783568 1.0 0.994805206924383 11 O75844,P50402,O60725,P48729,P02545 5 |
| Endothelin pathways 0.5607496794534477 1.1326751852268115 0.257350682163985 1.0 0.994805206924383 8 P16615,P00403 2 |
| 15q112 copy number variation syndrome 0.6372629843363528 1.1276577896682818 0.2594644705464892 1.0 0.994805206924383 4 Q9BSJ2,Q06787,Q7L576 3 |
| Mitochondrial long chain fatty acid betaoxidation 0.5805437893876437 1.1266046456671028 0.2599096740660633 1.0 0.994805206924383 14 Q9BY49,P23786,Q16836,O43772,P50416,P40939 6 |
| Ketogenesis and ketolysis 0.5520852209044214 1.1085185470022318 0.267637933700823 1.0 0.994805206924383 7 P23786,P53985 2 |
| Allograft rejection 0.5521833342953719 1.0331756328151973 0.3015217139733472 1.0 1.0 11 P30511,P10321,Q9BY49,P08670 4 |
| Ferroptosis 0.5965571089493004 1.0316310384382992 0.302244994351915 1.0 1.0 28 Q9NZ45,P09601,P45880,Q9Y277,P37268,Q9UKU0,P08195 7 |
| Thiamine metabolic pathways 0.5904306345660444 1.0127602992989424 0.3111746680044343 1.0 1.0 5 O14874 1 |
| Head and neck squamous cell carcinoma 0.5320732052123731 0.8458313197641755 0.3976468507437307 1.0 1.0 16 P62942,P11802,P31751,P04637 4 |
| Pparalpha pathway 0.4992588383681559 0.8424118170931616 0.3995574807212303 1.0 1.0 7 P23786,P11802 2 |
| Apoptosis modulation by hsp70 0.6715567758887868 0.7942417377845443 0.4270547147017138 1.0 1.0 3 O95831 1 |
| Adipogenesis 0.5140299600211211 0.7869029080683702 0.431338705041536 1.0 1.0 14 O75844,Q9NZ45,P43490,O00767,P02545 5 |
| Microrna network associated with chronic lymphocytic leukemia 0.8610271903323242 0.7807323824552188 0.4349599106371564 1.0 1.0 2 Q07820 1 |
| Type i collagen synthesis in the context of osteogenesis imperfecta 0.5093914423137432 0.7806398844451976 0.4350143267530884 1.0 1.0 13 Q96AY3,P07237,Q32P28 3 |
| Disruption of postsynaptic signaling by cnv 0.4895502253705563 0.7740243437894183 0.4389163954354034 1.0 1.0 8 Q13555,Q06787,Q7L576 3 |
| Glycosylation and related congenital defects 0.4914397132480081 0.7449733300957778 0.4562878428034416 1.0 1.0 10 Q9BV10,P15291,Q9BT22 3 |
| Camkk2 pathway 0.4889706070282338 0.6960786651530232 0.4863795667356085 1.0 1.0 12 O76024,P09601,Q9Y3D6 3 |
| Lncrnamediated mechanisms of therapeutic resistance 0.8291678110409229 0.6765302237521347 0.4987040635023245 1.0 1.0 2 P04637 1 |
| Burn wound healing 0.4650453694243641 0.6531782256030977 0.5136413861061433 1.0 1.0 8 P08670 1 |
| Spinal cord injury 0.501784600542474 0.6459477518868011 0.518313192966795 1.0 1.0 19 P62942,P11802,P08670,Q9NQC3,Q08722,P04637 6 |
| Envelope proteins and their potential roles in edmd physiopathology 0.4903518784228265 0.6350728290788337 0.5253809169636035 1.0 1.0 16 P42167,Q14739,Q9BTV4 3 |
| Caloric restriction and aging 0.5015957325651871 0.6183295807026132 0.5363581065874732 1.0 1.0 5 P43490 1 |
| Urea cycle and related diseases 0.8052732765723669 0.6013017775025568 0.5476390058885354 1.0 1.0 2 Q9Y619 1 |
| Pi3kaktmtor signaling pathway and therapeutic opportunities 0.4948830550169423 0.589926078042799 0.5552402098192089 1.0 1.0 5 Q15382,P31749 2 |
| Congenital generalized lipodystrophy cgl 0.7967591321065612 0.5751993392211922 0.5651564896293515 1.0 1.0 2 P31751 1 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5001126833244788 0.5328708192428114 0.5941230062842697 1.0 1.0 27 Q14739,Q9UBM7,P04035,P14324,Q15392,Q16850,Q15800,O00767,O75845,P37268,Q14534 11 |
| Leukocyteintrinsic hippo pathway functions 0.4311054284472518 0.5103240859880657 0.6098244311826091 1.0 1.0 7 Q13043,Q96GC9 2 |
| Regulation of wnt bcatenin signaling by small molecule compounds 0.4652377026655802 0.4132341534747445 0.6794350675473573 1.0 1.0 4 P49841,P48729,O14641 3 |
| Vitamin d receptor pathway 0.4340753170919064 0.3819969520549686 0.7024636254256031 1.0 1.0 15 P20020,P08183,P09493,Q96KA5,P11413,Q92604,Q5VV42 7 |
| Riboflavin and coq disorders 0.4001470075744718 0.3698765832769847 0.7114744498837622 1.0 1.0 7 Q8NI60,Q8NFF5,Q5T2R2,Q86YH6 4 |
| Nonsmall cell lung cancer 0.4331894862964391 0.3621323540128182 0.7172531271083855 1.0 1.0 16 Q13043,P11802,P31751,P04637 4 |
| Mirna regulation of prostate cancer signaling pathways 0.3997248968363195 0.3496080676986678 0.7266328554419492 1.0 1.0 8 P62993,P42345,Q8NCF5,Q02750,P49841,P04637,P35222 7 |
| Heme biosynthesis 0.4307582241919294 0.3374688047361931 0.7357635245224294 1.0 1.0 5 P36551 1 |
| Genes related to primary cilium development based on crispr 0.438933103441213 0.328539830175357 0.7425035338817951 1.0 1.0 20 Q8NCM8,Q96J42,Q9Y366,A0AVF1,O95684,Q10713 6 |
| Vitamin a and carotenoid metabolism 0.432129360135372 0.3008057533223128 0.7635626209672948 1.0 1.0 4 Q8WTV0 1 |
| Apoptosis 0.4070666623354563 0.2951656463505702 0.7678673437127734 1.0 1.0 13 Q9NR28,Q07820 2 |
| Melanoma 0.4133166522477749 0.2900828521932282 0.7717528540215415 1.0 1.0 15 P62993,P11802,P31751,P04637 4 |
| Inclusion body myositis 0.5164801113906532 0.2899792309381128 0.7718321265876757 1.0 1.0 3 P05067 1 |
| Pkcgamma calcium signaling pathway in ataxia 0.5118131868131883 0.277958215564359 0.7810444343771383 1.0 1.0 3 Q15118,P23634 2 |
| Regucalcin in proximal tubule epithelial kidney cells 0.3995050866098473 0.2702726061223598 0.7869505385314843 1.0 1.0 6 Q8NE86,P31749,Q13283,P42345,Q16611 5 |
| Progeriaassociated lipodystrophy 0.3885958305204713 0.2508059646552624 0.8019641298193583 1.0 1.0 11 O60725 1 |
| Mirna regulation of p53 pathway in prostate cancer 0.4936173125670303 0.2334797829371898 0.8153888666669653 1.0 1.0 3 P04637 1 |
| Extracellular vesiclemediated signaling in recipient cells 0.4094531464688229 0.2322341833914771 0.8163561289135259 1.0 1.0 4 P31749,P35222,Q9NWH9 3 |
| Metapathway biotransformation phase i and ii 0.4296772654197155 0.209623686266821 0.8339613913892889 1.0 1.0 26 Q6UW02,O15217,P07099,P21964,Q8NCH0,Q16850,P78417,Q99735 8 |
| Nephrotic syndrome 0.3874474048221979 0.1987715699481278 0.8424414361033166 1.0 1.0 14 O75844,Q9BT22 2 |
| Target of rapamycin tor signaling 0.3695214353614463 0.1759916514684721 0.8603005012426326 1.0 1.0 11 P62942,Q15382,P04035 3 |
| G1 to s cell cycle control 0.4206682340926194 0.159664017993054 0.8731457466912909 1.0 1.0 27 P33991,P11802,Q9Y619,Q14566,Q99640 5 |
| Fatty acid betaoxidation 0.402486838172341 0.1593262820131182 0.8734118151813548 1.0 1.0 21 P49748,Q16836,P23786,O43772,P50416,P40939,Q9UKU0 7 |
| Photodynamic therapyinduced hif1 survival signaling 0.3689799743678957 0.1585564627755848 0.8740183324339845 1.0 1.0 12 Q07820,P53985 2 |
| Ciliopathies 0.4144388773661967 0.1573368338958186 0.8749793924989662 1.0 1.0 25 Q13432,O43924,Q8NCM8,Q96RK4,Q15051,Q9Y366,Q10713,Q15555,Q9NQH7 9 |
| Leptininsulin signaling overlap 0.4565934065934083 0.1554787845395366 0.8764438780335657 1.0 1.0 3 P31749,O14654 2 |
| 4hydroxytamoxifen dexamethasone and retinoic acids regulation of p27 expression 0.3360836083608486 0.1194759859656664 0.9048982641707046 1.0 1.0 7 P31749,P06730,Q96KB5,P42345,P28482,Q02750 6 |
| Endometrial cancer 0.3603367472504529 0.1126556712860575 0.910303546629271 1.0 1.0 13 P04637,P31751 2 |
| Ppar signaling pathway 0.375157324800477 0.1092487293354518 0.913005211156322 1.0 1.0 17 Q15067,P23786,P50416,O00767,Q9UKU0,O95864 6 |
| Fluoropyrimidine activity 0.3546773543049839 0.0932167052469775 0.9257314033055208 1.0 1.0 13 P00374,P31350 2 |
| Proximal tubule transport 0.3420240803751707 0.0657524167034282 0.947574940174246 1.0 1.0 12 P05023,Q9Y5K8,P08183,P11166,O15439,P36543,P08195 7 |
| Mapk cascade 0.3358988455195235 0.0649180162799595 0.9482392759343056 1.0 1.0 5 Q02750,P62993,P28482,Q16539 4 |
| Synaptic signaling pathways associated with autism spectrum disorder 0.3281753665062301 0.0506675592659557 0.959590427387066 1.0 1.0 10 Q15382,P31751 2 |
| Joubert syndrome 0.368660677516137 0.0478559216532937 0.9618310685382804 1.0 1.0 20 Q13432,P41208,O43924,Q10713 4 |
| Omega3 omega6 fatty acid synthesis 0.3211708911827111 0.0375427950259213 0.9700522186852178 1.0 1.0 6 Q15067,O95864 2 |
| Onecarbon metabolism and related pathways 0.3495840055724361 0.0364300036781546 0.9709394905764492 1.0 1.0 16 Q9Y6K0,Q9HBU6 2 |
| Aryl hydrocarbon receptor pathway wp2586 0.3080308030803161 0.033980559673377 0.9728926528810632 1.0 1.0 7 P24941,Q16543,P28482,P07900,Q02750,O00170 6 |
| Drug induction of bile acid pathway 0.3594198786739802 0.0331286529307355 0.9735719935512894 1.0 1.0 3 P08183 1 |
| S1p receptor signal transduction 0.3204694515377114 0.0283265978198827 0.9774016671157122 1.0 1.0 10 Q9NRA0 1 |
| Folate metabolism 0.3469238345056559 0.028221304812844 0.9774856452069124 1.0 1.0 16 P00374 1 |
| Sarscov2 b117 variant antagonises innate immune activation 0.473770942048878 0.0271013477459327 0.978378899810898 1.0 1.0 2 Q7Z434 1 |
| Cell differentiation expanded index 0.4564680032957879 0.0219128779901907 0.9825174520915384 1.0 1.0 2 Q15910 1 |
| Neovascularisation processes 0.3357142857142877 0.019123954450184 0.984742222035122 1.0 1.0 3 P31749,P28482 2 |
| Interleukin1 induced activation of nfkb 0.3790167536391061 0.0111686513519211 0.9910888907818356 1.0 1.0 2 P61088 1 |
| Myd88 distinct inputoutput pathway 0.3790167536391061 0.0111686513519211 0.9910888907818356 1.0 1.0 2 P61088 1 |
| Serotonin and anxiety 0.295523207909909 0.0093472961700616 0.992542045303483 1.0 1.0 2 Q06787 1 |
| Alzheimers disease and mirna effects 0.3789360974482514 0.0073569886197973 0.9941300253186478 1.0 1.0 91 P28074,Q96GC9,Q13885,P07437,P21796,Q96IX5,P45880,P05067,P25787,P78536,O95197,P0DP25,Q9Y277,O00487,P28070,P16615,P31751,Q9H0B6,P12236,Q9NQC3,P05141,P60900,P25786,P20618,Q92542,P28072,P49721,P12235 28 |
| Quercetin and nfkb ap1 induced apoptosis 0.2903846153846177 0.0039835367907049 0.996821605903401 1.0 1.0 3 P00395,Q14145 2 |
|
|
